Table 2:

Post LT Monitoring Questions and Responses (N=71)

Survey Question	Pulmonologists (N=49)	Cardiologist (N=22)
Frequency of Echocardiography to guide adjustment of targeted therapy in PoPH after LT
Every 1–2 months	2 (4.2%)	2 (9.5%)
Every 3 months	19 (40.4%)	10 (47.6%)
Every 4–5 months	3 (6.4%)	3 (14.3%)
Every 6 months	17 (36.2%)	6 (28.6%)
Every 7–12 months	5 (10.6%)	0 (0.0%)
As Needed	1 (2.1%)	0 (0.0%)
Frequency of RHC to guide adjustment of targeted therapy in PoPH after LT
Every 1–2 months	0 (0.0%)	2 (9.1%)
Every 3 months	6 (13.6%)	2 (9.1%)
Every 4–5 months	2 (4.5%)	2 (9.1%)
Every 6 months	13 (29.5%)	7 (31.8%)
Every 7–12 months	12 (27.2%)	5 (22.7%)
Based on Echocardiogram	3 (6.8%)	2 (9.1%)
As Needed	8 (18.2%)	2 (9.1%)
Frequency of six-minute walk test to guide adjustment of targeted therapy in PoPH after LT
Every 1–2 months	4 (8.9%)	2 (12.5%)
Every 3 months	30 (66.7%)	8 (50.0%)
Every 4–5 months	1 (2.2%)	2 (12.5%)
Every 6 months	8 (17.8%)	4 (25.0%)
Every 7–12 months	2 (4.4%)	0 (0.0%)
As Needed	0 (0.0%)	0 (0.0%)
Frequency of BNP/NTproBNP to guide adjustment of targeted therapy in PoPH after LT
Every 1–2 months	5 (11.9%)	3 (14.3%)
Every 3 months	24 (57.1%)	13 (61.9%)
Every 4–5 months	1 (2.4%)	3 (14.3%)
Every 6 months	9 (21.4%)	1 (4.8%)
Every 7–12 months	2 (4.8%)	0 (0.0%)
As Needed	1 (2.4%)	1 (4.8%)

Abbreviations: PoPH = Portopulmonary Hypertension, LT = Liver Transplant, RHC = Right Heart Catheterization, BNP = Brain Natriuretic Peptide, NTproBNP = N-Terminal prohormone of Brain Natriuretic Peptide